ORDER NOW

This report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of US. The report identifies the key trends in the healthcare market of US. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of US.

Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by the publisher's team of industry experts.

In 2012, US was the third most populated country in the world with a population of approximately 316.2 million. The population of US is increasing at a slow rate of growth due to a negative balance between the mortality and birth rate and low fertility rate. The decline in the population of the working age group and the increasing elderly population are matters of concern for US policy planners.

The pharmaceutical market in US was estimated at approximately $359 billion in 2012 and is expected to reach approximately $475 billion by 2020, with a projected CAGR of 3.5%. The medical device market size was approximately $138.9 billion in 2012 and is expected to reach approximately $206 billion by 2020, at a projected CAGR of 5.1%.

Reasons to buy:

The report on US comprehensively covers both the pharmaceutical and medical devices markets of US. The report will enhance your decision-making capability. It will allow you to:
- Develop business strategies by understanding the trends shaping and driving the healthcare market of US.

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact US healthcare market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Organize your sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidations, investments and strategic partnerships.

- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of US.


Pages: 371
Published: May 2013
Publisher: Global Data

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 19
2.1 Report Guidance 19
3 Overview of the Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Supply Channels 27
3.1.3 Market Segments 30
3.1.4 Overview of Major Disease Segments 46
3.1.5 Major Players 50
3.2 Medical Device Market 105
3.2.1 Market Overview 105
3.2.2 Overview of Top Five Segments 107
3.2.3 Diagnostic Market 118
3.2.4 Major Players 120
3.3 Market Drivers and Barriers 158
3.3.1 Drivers 158
3.3.2 Barriers 160
4 Market Access 165
4.1.1 Reimbursement and Payer Landscape 165
4.1.2 Health Insurance and Managed Care in US 166
4.1.3 Overview of Insurance Providers 171
4.1.4 Patient Share in Healthcare Spending 184
4.1.5 Prescription Drug Price Trend 186
4.1.6 Pricing Policies 187
4.2 Regulatory Landscape 190
4.2.1 Overview of Regulatory Agencies 190
4.2.2 New Drug Approval Process 191
4.2.3 Approval Process of Biological Products as Biosimilar or Interchangeable 208
4.2.4 New Medical Device Approval Process 209
4.2.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 217
4.2.6 Licensing Process for Pharmaceutical Exports and Imports 222
4.2.7 Intellectual Property Rights 236
4.2.8 Clinical Trial Regulations 239
4.2.9 Pharmaceutical Advertising Regulations 244
4.2.10 Pharmacy Regulations 245
4.2.11 Labeling and Packaging Regulations 247
5 Country Analysis 250
5.1 Political Environment 250
5.1.1 Political Structure 250
5.1.2 Analysis of Current Political Environment 251
5.1.3 Healthcare Policy Initiatives 254
5.2 Economic Landscape 259
5.3 Economic Indicators 265
5.3.1 Gross Domestic Product 265
5.3.2 Gross National Income 269
5.3.3 Inflation 270
5.3.4 Currency Exchange Rate 273
5.3.5 Foreign Direct Investment 276
5.3.6 Foreign Exchange Reserves 277
5.3.7 Trade Balance 278
5.3.8 Government Structural Balance 281
5.3.9 Government Net Debt 283
5.3.10 Major Industries 285
5.4 Demography 286
5.4.1 Population 286
5.4.2 Education and Literacy 303
5.4.3 Employment 305
5.4.4 Disease Burden 307
5.5 Healthcare Infrastructure 310
5.5.1 Healthcare Facilities 310
5.5.2 Healthcare Parameters 318
5.5.3 Environmental Health 322
5.5.4 Healthcare Personnel 327
5.6 Healthcare Expenditure 328
5.6.1 Overview 328
5.6.2 Major Components of Healthcare Spending 329
5.6.3 Share of Public and Private Sectors 331
5.6.4 Spending in Pharmaceutical R&D 332
5.7 Trade Associations 334
5.7.1 Pharmaceutical Research and Manufacturers of America 334
5.7.2 Consumer Healthcare Products Association 334
5.7.3 International Pharmaceutical Excipients Council 334
5.7.4 Advanced Medical Technology Association 335
5.7.5 National Association for Home Care & Hospices 335
5.7.6 Biotech Industry Association 335
5.7.7 The Society of Chemical Manufacturers and Affiliates 336
5.8 Trade Fairs 336
6 Opportunities and Challenges 339
6.1 Opportunities 339
6.2 Challenges 341
7 Appendix 344
7.1 Abbreviations 344
7.2 Bibliography 353
7.3 Methodology 369
7.3.1 Coverage 369
7.3.2 Secondary Research 369
7.3.3 Forecasting 370
7.3.4 Expert Panel Validation 370
7.4 Contact Us 370
7.5 Disclaimer 371

ORDER NOW